IFIH1 and interstitial lung disease: The most prevalent autoantibodies among patients with ILD were anti-Jo1 [25/64 (39.1%)] and anti-MDA-5 [8/64 (12.5%)], both significantly more prevalent than in non-ILD patients [vs. 4/106 (3.8%), p < 0.001; vs. 3/106 (2.8%), p = 0.021].